Stockreport

Amphastar Pharmaceuticals Inc Reports Robust Revenue Growth and Strong Full-Year Performance [Yahoo! Finance]

Amphastar Pharmaceuticals, Inc.  (AMPH) 
Last amphastar pharmaceuticals, inc. earnings: 3/12 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.amphastar.com/investor-relations
PDF Adjusted Non-GAAP Net Income : $46.9 million for Q4 2023, reflecting a more comprehensive view of profitability. GAAP Diluted EPS : $0.68 for Q4 2023, showing earning [Read more]